University of Exeter: against COVID-19 University
University of Exeter is partner of the global project 'COVID-19 Genomics UK (COG-UK) Consortium'
The team is working closely with the Clinical Diagnostics teams at the Royal Devon and Exeter NHS Trust and in the surrounding area.
https://www.exeter.ac.uk/
'COVID-19 Genomics UK (COG-UK) Consortium' is a collaboration between the NHS, Public Health England and other UK public health agencies, the Wellcome Sanger Institute, University of Cambridge and other academic institutions.
Project: COVID-19 Genomics UK (COG-UK) Consortium
Research Group: Cardiovascular Epidemiology Unit
Project Description: The COVID-19 Genomics UK (COG-UK) Consortium aims to increase the current capacity for SARS-CoV-2 genetic sequencing in the UK. This sequencing data will be used to understand the epidemiology and spread of the virus, and to monitor and evaluate interventions for COVID-19. SARS-CoV-2 genomic data will be integrated with NHS electronic health records and other existing genomic data to generate insights into susceptibility to COVID-19. From within the DPHPC, Professor John Danesh is a member of the COG-UK Steering Group, Dr Ewan Harrison will serve as the Scientific Project Manager and Dr Michael Chapman will lead the health informatics component.
Contributors:
Dr Stephen Michell, Senior Lecturer in Molecular Microbiology, College of Life and Environmental Sciences
Dr Ben Temperton, Senior Lecturer in Bioinformatics, College of Life and Environmental Sciences
Dr Aaron Jeffries, Senior Research Fellow, University of Exeter Medical School
Professor David Studholme, Associate Professor in Bioinformatics, College of Life and Environmental Sciences
Dr Jane Masoli, Academic Geriatrician, Royal Devon and Exeter NHS Trust and University of Exeter Medical School
https://www.cogconsortium.uk/about/
.jpg)
